Strategies for improving the therapeutic efficacy of mesenchymal stem cells in the treatment of nonhealing wounds
10.3969/j.issn.2095-4344.2176
- Author:
Xianyao WANG
1
Author Information
1. Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University
- Publication Type:Journal Article
- Keywords:
Genetic modifications;
Mesenchymal stem cells;
Nonhealing wounds;
Preconditioning;
Review;
Stem cells;
Wound repair
- From:
Chinese Journal of Tissue Engineering Research
2020;25(7):1081-1087
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND: Mesenchymal stem cell-based therapy is pursued aggressively with promising preclinical studies and higher future prospect in the treatment of nonhealing wounds. OBJECTIVE: To review the strategies for improving the efficacy of mesenchymal stem cells in the treatment of nonhealing wounds, which are expected to provide theoretical basis for clinical treatment of nonhealing wounds. METHODS: Wanfang, CNKI, PubMed and Web of Science were searched for articles about the application of mesenchymal stem cells in nonhealing wounds from March 2002 to March 2020. The key words were “mesenchymal stem cells, nonhealing wounds (nonhealing chronic wounds), wound repair, tissue regeneration” in Chinese and “mesenchymal stem cells, nonhealing chronic wound, wound repair, tissue regeneration” in English. After excluding outdated and repetitive viewpoints, the retrieved literature was sorted out and a total of 64 articles were included for analysis. RESULTS AND CONCLUSION: (1) The formation mechanism of nonhealing wounds was summarized. (2) The molecular mechanisms of mesenchymal stem cells in the treatment of nonhealing wounds were summarized, such as direct differentiation, paracrine, immunomodulatory, mobilization resident stem cells to participate in wound repair. (3) This paper summarized the improvement of the efficacy of mesenchymal stem cells in the treatment of nonhealing wounds, such as gene modification and pretreatment. (4) This study can provide a theoretical basis for improving the efficacy of mesenchymal stem cells in the treatment of nonhealing wounds.
